Monthly Archives: May 2018

We thank the authors for their letter in response to our article, and welcome the opportunity to address their concerns. In their letter, Razjouyan et al suggest that there may be benefits to anesthesia assistance (AA) for colonoscopy not discussed i… Continue reading →

Although there have been meta-analyses of the effects of exercise prehabilitation on patients undergoing colorectal surgery, little is known about the effects of nutrition-only (oral nutritional supplements and/or counseling) and multi-modal (oral nutr… Continue reading →

We thank Firl et al for their thoughtful comments on our study proposing the Metroticket 2.0 Model1: a prognostic tool for patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC). Some of their observations are worth a reply. Continue reading →

De Boer et al have recently extended our observation of low systemic tryptophan (TRP) levels in inflammatory bowel disease (IBD)1 by showing increased levels of TRP and 4 other aromatic amino acids in the stools of 30 pediatric patients with IBD.2 The… Continue reading →

We would like to thank Srijit et al for their thoughtful letter which raises several important considerations concerning our published article and potential implications for a better understanding of the conceptual basis of our study, and the potentia… Continue reading →

We read with great interest the letter submitted by Ponzetto and Holton. We want to thank them for highlighting different potential mechanisms on how CFTR abnormalities can lead to an increased cancer risk.1–3 Continue reading →

We thank Dr Chung for his comments on our recent manuscript. As he states, the majority of studies relating microRNA (miR)-122 in the liver have focused on its role on hepatic viral infection and nonalcoholic fatty liver disease. Yet, little is known a… Continue reading →

We enthusiastically read the well-designed, population-based study by Bielawska et al1 that evaluated the important question of risks of anesthesia assistance (AA) in outpatient colonoscopy. In this secondary data analysis, the authors selected 2 co… Continue reading →

A high rate of hepatitis B surface antigen (HBsAg) seroclearance after cessation of nucleoside therapy has been reported previously in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B.1–3 More important, patients who were not … Continue reading →